Clinical improvement following treatment at TransBarrier® is documented, eight years after stroke. For further information regarding additional patients please see Rapid improvement of chronic stroke deficits …: three consecutive cases. CNS Drugs. 2011 Feb;25(2):145-155.

Disclaimer: Individual results vary, not all patients respond. Continuing maintenance treatment may be necessary to maintain the clinical response. The method utilized for this indication is off-label.  Please see the Terms of Use. Copyright 2015 TransBarrier®, all rights reserved. Issued and pending U.S. and foreign patents, including, but not limited to, Australian patent 758523.